<!– Name:DistributionId Value:8754920 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1266861 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:48e2938c-c5a4-4022-a259-69505a3522da –> MELBOURNE, Australia,...
<!– Name:DistributionId Value:8755453 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1199811 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:afb56240-e17c-4f6e-a0b8-24f8631c5fe5 –> New York,...
Vancouver, British Columbia–(Newsfile Corp. – February 23, 2023) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTC: CNTRF) (“CENTR Brands” or the “Company“) is pleased to...
Toronto, Ontario–(Newsfile Corp. – February 23, 2023) – High Fusion Inc. (CSE: FUZN) (“High Fusion” or the “Company“) is pleased to announce that yesterday it has entered...
Vancouver, British Columbia–(Newsfile Corp. – February 23, 2023) – Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC) (“Xebra”) a cannabis company, announces that effective Tuesday, February 28,...
Product expected to be 100% absorbed within Vext’s retail network, contributing to a lower cost base Vancouver, British Columbia–(Newsfile Corp. – February 23, 2023) – Vext...
San Diego, California–(Newsfile Corp. – February 23, 2023) – Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid...
<!– Name:DistributionId Value:8754525 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:8777 –> <!– Name:CustomerId Value:1244594 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:01a50816-19db-46b4-b7da-98d3789d32f8 –> NEW YORK,...
Red Light Holland will release its financial and operational results for the quarter ended December 31, 2022, prior to the opening of the financial markets on...
PharmaDrug is positioning to become a leader of DMT-based therapeutics for ocular disease and neuropsychiatric conditions Toronto, Ontario–(Newsfile Corp. – February 22, 2023) – PharmaDrug Inc....